ML20198J252
ML20198J252 | |
Person / Time | |
---|---|
Issue date: | 03/11/1997 |
From: | Bell H NRC OFFICE OF THE INSPECTOR GENERAL (OIG) |
To: | Morrison D NRC OFFICE OF NUCLEAR REGULATORY RESEARCH (RES) |
Shared Package | |
ML20013E023 | List:
|
References | |
FRN-62FR32552, RULE-PR-30, RULE-PR-32 AF70-1-044, AF70-1-44, NUDOCS 9801140082 | |
Download: ML20198J252 (1) | |
Text
_ - -
g
,s en:q l / o g UNITED STATES
["
g g
E I NUCLEAR REGULATORY COMMISSION WASHil4G10N. D.C. 20566-0001 [ 7O-/
%,o.,*J n
PD L March 11,1997 OfflCE OF THE INSPECTOR GENERAL MEMORANDUM TO: David L. Morrison, Director Office of Nuclear Regulatory Research l yphtf FROM: 'Hubert T. Bell Inspector General SUDJECT: PROPOSED RULE: EXEMPT DISTRIBUTION OF A RADIOACTIVE DRUG CONTAINING ONE MICROCURIE OF CARBON 14 UREA (PARTS 30 AND 32)
The inspector General Act requires that my office review statutes, regulations and policies and to make recommendations conceming the impact of these statutes, regulations and policies on agency programs and operations. The purpose of this review is to analyze and comment on their effect on the economy and efficiency of programs and operations administered by the agency.
In accordance with that statutory obligation, we have reviewed PROPOSED RULE: EXEMPT DISTRIBUTION OF A RADIOACTIVE DRUG CONTAINING ONE MICROCURIE OF CARBON-14 UREA (PARTS 30 AND 32).- We have no comments at this time. However, we request that you provide this office with copies of comments received in response to the Federal Register Notice and revisions to the proposed rule, if you have questions regarding this matter, my point of contact is Maryann L. Grodin, she may be reached at 415-5945.
I I
9901140082 990109 '